Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;55(1):39-55.
doi: 10.1016/j.jpainsymman.2017.08.008. Epub 2017 Aug 31.

Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy

Carmen W Sullivan  1 , Heather Leutwyler  1 , Laura B Dunn  2 , Bruce A Cooper  1 , Steven M Paul  1 , Jon D Levine  3 , Marilyn Hammer  4 , Yvette P Conley  5 , Christine A Miaskowski  6
Affiliations

Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy

Carmen W Sullivan et al. J Pain Symptom Manage. 2018 Jan.

Abstract

Context: Patients with breast cancer who undergo chemotherapy (CTX) experience between 10 and 32 concurrent symptoms. An evaluation of how these symptoms cluster together and how these symptom clusters change over time may provide insights into how to treat these multiple co-occurring symptoms.

Objectives: The purposes of this study were to determine the occurrence rates and severity ratings for 38 common symptoms, evaluate for differences in the number and types of symptom clusters, and evaluate for changes over time in these symptom clusters (i.e., before CTX, the week after CTX, and two weeks after CTX).

Methods: At each of the assessments, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of the 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters.

Results: Although across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, eight distinct symptom clusters were identified, only five were relatively stable across both dimensions and across time (i.e., psychological, hormonal, nutritional, gastrointestinal, and epithelial). Two of the additional clusters varied by time but not by symptom dimension (i.e., sickness behavior and weight change). The CTX neuropathy cluster was identified only at the assessment performed in the week after CTX.

Conclusion: These findings provide insights into the most common symptom clusters in patients undergoing CTX for breast cancer. In addition, the most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.

Keywords: Symptoms; breast cancer; chemotherapy; symptom clusters; symptom occurrence; symptom severity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Miaskowski C. Future directions in symptom cluster research. Semin Oncol Nurs. 2016;32:405–415. - PubMed
    1. Miaskowski C, Barsevick A, Berger A, et al. Advancing symptom science through symptom cluster research: Expert panel proceedings and recommendations. J Nat Cancer Inst. 2017;109(4) - PMC - PubMed
    1. Nguyen J, Cramarossa G, Bruner D, et al. A literature review of symptom clusters in patients with breast cancer. Expert Rev Pharmacoecon Outcomes Res. 2011;11:533–539. - PubMed
    1. Barsevick AM. Defining the symptom cluster: How far have we come? Semin Oncol Nurs. 2016;32:334–350. - PubMed
    1. Ward Sullivan CM, Leutwyler H, Dunn LB, et al. Differences in symptom clusters identified using symptom occurrence rates versus severity ratings in patients with breast cancer undergoing chemotherapy. Eur J Oncol Nurs. 2017;28:122–132. - PMC - PubMed

Publication types

Substances